feedback welcome

Imipramine-hypericum

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][draft revision]
 
Line 3: Line 3:
| to = hypericum  
| to = hypericum  
| stop =  
| stop =  
-
* '''Before day 1:''' gradually reduce dosage of imipramine to a maximum of 75 mg/day, when this dosage is > 75 mg/day.
+
{{stopImipramine}}
-
* '''Day 1:''' reduce dosage of imipramine to 50 mg/day.
+
-
* '''Day 8:''' reduce dosage of imipramine to 25 mg/day.
+
-
* '''Day 15:''' stop administration of imipramine.
+
| start =  
| start =  
-
* '''Day 15-22:''' a wash-out period of one week is necessary.
+
* '''Day 8-15:''' a wash-out period of one week is necessary.
-
* '''Day 23:''' start administration of hypericum in a dosage of 300 mg three times a day (900 mg/day).
+
* '''Day 16:''' start administration of hypericum in a dosage of 300 mg three times a day (900 mg/day).
| caveat = {{caveSS}}
| caveat = {{caveSS}}
| info = {{HypericumInfo}}
| info = {{HypericumInfo}}
-
{{review}}
 
}}
}}

Current revision as of 10:49, 4 November 2015

Imipramine
Type Antidepressant
Group TCA
links
Medscape Imipramine
PubChem 3696
PubMed Imipramine
Kompas (Dutch) Imipramine
Wikipedia Imipramine
Hypericum
Type Antidepressant
Group other
links
EMEA 10130408en
PubMed Hypericum
Kompas (Dutch) hypericum extract
Wikipedia St John's wort

Switch medication from imipramine to hypericum.

Nietinrijdenbord.png Stop imipramine
Eenrichtingbord.png Start hypericum
Letopbord.png Cave
Infobord.png More information
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About